Duchenne Muscular Dystrophy – Asian Scientist Magazine

duchenne muscular dystrophy

FDA Approves Duchenne Muscular Dystrophy Drug

Scientists in Australia had originally developed Eteplirsen®, a drug that treats a rare and fatal muscle-wasting disease affecting one in 3,500 boys worldwide.

In the Lab

Perfecting Gene Editing For DMD On iPS Cells

By combining iPS and gene editing technology, correcting the mutation in Duchenne muscular dystrophy patients has been made more precise.

Pharma

Duchenne Muscular Dystrophy Drug Completes Phase II Trial

An Australian-developed compound for the treatment of Duchenne Muscular Dystrophy has undergone a Phase II study in the U.K.

EDITOR’S PICK

10 Years Of Celebrating Asia’s Researchers

Every year, Asian Scientist Magazine publishes Asian Scientist 100, a carefully curated list of the best and brightest researchers and leaders in SETM in Asia. This year we complete a decade of doing so.
Learning From Environmental Defenders

Drawing on traditional knowledge systems, environmental researchers and policymakers in Asia are working with indigenous communities to design better strategies for environmental conservation.
The Equalizers

Across Asia, people with disabilities are breaking physical and social barriers to STEM fields, opening the way for others.

FDA Approves Duchenne Muscular Dystrophy Drug

Perfecting Gene Editing For DMD On iPS Cells

Duchenne Muscular Dystrophy Drug Completes Phase II Trial

EDITOR’S PICK

10 Years Of Celebrating Asia’s Researchers

Learning From Environmental Defenders

The Equalizers